Trial Profile
Single-center, open-label study to investigate the effect of multiple-dose ACT-129968 on the pharmacokinetics (PK) of single-dose simvastatin in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Mar 2015
Price :
$35
*
At a glance
- Drugs Setipiprant (Primary) ; Simvastatin
- Indications Asthma; Seasonal allergic rhinitis
- Focus Pharmacokinetics
- 18 Oct 2014 Status changed from active, no longer recruiting to completed according to results published in the European Journal of Clinical Pharmacology.